[Intermittent melphalan-predniso(lo)ne massive-dose therapy of plasmacytoma].
D001772:Blood Cell Count; D001792:Blood Platelets; D004338:Drug Combinations; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects; D010954:Plasmacytoma / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced
D004338:Drug Combinations; D011239:Prednisolone; D008558:Melphalan; D011241:Prednisone
Die intermittierende Melphalan-Predniso(lo)n-Stosstherapie des Plasmozytoms.